Biomecite Diagnostics has been accepted to present at the Biotech Showcase January 11, 2016 in San Francisco. CEO Gerard Eldering will present on Monday at 4:30.

Biotech Showcase™ is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Now in its eighth year, Biotech Showcase 2016 is expected to attract upwards of 2,100 attendees.

2 Responses to “Biomecite to Present at Biotech Showcase during JPMorgan Week January 11, 2016”

  1. Kalea

    Buenas, estoy de acuerdo contigo , aunque quizás también falta una razón “por abr8#imiento&ur221;, encuentras a veces cada twitts que no alcanzar a saber que pretende el autor con ello, buen post, un saludo.

Leave a Reply

  • (will not be published)